Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $74M | 75M | 0.99 |
2023-09-30 | $69M | 75M | 0.92 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1